Lisanti Capital Growth’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-98,130
| Closed | -$7.7M | – | 142 |
|
|
2021
Q2 | $7.7M | Buy |
+98,130
| New | +$7.7M | 0.95% | 36 |
|
|
2021
Q1 | – | Sell |
-70,015
| Closed | -$5.86M | – | 145 |
|
|
2020
Q4 | $5.86M | Sell |
70,015
-81,275
| -54% | -$6.81M | 0.81% | 53 |
|
|
2020
Q3 | $5.42M | Buy |
+151,290
| New | +$5.42M | 1% | 54 |
|
|
2019
Q2 | – | Sell |
-73,605
| Closed | -$1.71M | – | 109 |
|
|
2019
Q1 | $1.71M | Buy |
+73,605
| New | +$1.71M | 0.61% | 72 |
|